Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)
暂无分享，去创建一个
K. Nishio | Daisuke Ishikawa | T. Sekiya | Aya Ohtsubo | T. Kikuchi | Satoshi Watanabe | K. Nozaki | K. Sakai | H. Yoshizawa | Y. Saida | Tomohiro Tanaka | S. Shoji | J. Koshio | S. Miura | A. Aoki | K. Koyama | N. Matsumoto | Toshiya Fujisaki | Kohei Kushiro | Y. Goto | R. Suzuki | A. Ishida | Tomosue Kajiwara | N. Yanagimura | Tetsuya Abe | T. Abe